Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension

NCT00376636 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: SPP635 (drug)

Sponsor

Speedel Pharma Ltd.